101 related articles for article (PubMed ID: 10470156)
1. Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis.
Anastasiadis AG; Lemm I; Radzewitz A; Lingott A; Ebert T; Ackermann R; Ryffel GU; Schulz WA
Anticancer Res; 1999; 19(3A):2105-10. PubMed ID: 10470156
[TBL] [Abstract][Full Text] [Related]
2. Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma.
Clairmont A; Ebert T; Weber H; Zoidl C; Eickelmann P; Schulz WA; Sies H; Ryffel GU
Cancer Res; 1994 Mar; 54(5):1319-23. PubMed ID: 8118822
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a naturally occurring mutation (L107I) in the HNF1 alpha (MODY3) gene.
Cervin C; Orho-Melander M; Ridderstråle M; Lehto M; Barg S; Groop L; Cilio CM
Diabetologia; 2002 Dec; 45(12):1703-8. PubMed ID: 12488960
[TBL] [Abstract][Full Text] [Related]
4. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.
Rebouissou S; Vasiliu V; Thomas C; Bellanné-Chantelot C; Bui H; Chrétien Y; Timsit J; Rosty C; Laurent-Puig P; Chauveau D; Zucman-Rossi J
Hum Mol Genet; 2005 Mar; 14(5):603-14. PubMed ID: 15649945
[TBL] [Abstract][Full Text] [Related]
5. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
8. Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha.
Sel S; Ebert T; Ryffel GU; Drewes T
Cancer Lett; 1996 Mar; 101(2):205-10. PubMed ID: 8620471
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
[TBL] [Abstract][Full Text] [Related]
10. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system.
Park IN; Cho IJ; Kim SG
Mol Pharmacol; 2004 Jun; 65(6):1475-84. PubMed ID: 15155840
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis.
Pontoglio M
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S140-3. PubMed ID: 11065346
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of the Atlantic salmon hepatocyte nuclear factor (HNF) 1 promoter by the orphan nuclear receptors HNF4 and chicken ovalbumin upstream promoter transcription factor I (COUP-TFI).
McNair A; Cereghini S; Brand H; Smith T; Breillat C; Gannon F
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):557-64. PubMed ID: 11085951
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome.
Tronche F; Ringeisen F; Blumenfeld M; Yaniv M; Pontoglio M
J Mol Biol; 1997 Feb; 266(2):231-45. PubMed ID: 9047360
[TBL] [Abstract][Full Text] [Related]
14. MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X).
Bjørkhaug L; Ye H; Horikawa Y; Søvik O; Molven A; Njølstad PR
Biochem Biophys Res Commun; 2000 Dec; 279(3):792-8. PubMed ID: 11162430
[TBL] [Abstract][Full Text] [Related]
15. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
[TBL] [Abstract][Full Text] [Related]
16. The bifunctional protein DCoH modulates interactions of the homeodomain transcription factor HNF1 with nucleic acids.
Rhee KH; Stier G; Becker PB; Suck D; Sandaltzopoulos R
J Mol Biol; 1997 Jan; 265(1):20-9. PubMed ID: 8995521
[TBL] [Abstract][Full Text] [Related]
17. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma.
Wang W; Hayashi Y; Ninomiya T; Ohta K; Nakabayashi H; Tamaoki T; Itoh H
J Pathol; 1998 Mar; 184(3):272-8. PubMed ID: 9614379
[TBL] [Abstract][Full Text] [Related]
18. LRH-1/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication.
Cai YN; Zhou Q; Kong YY; Li M; Viollet B; Xie YH; Wang Y
Cell Res; 2003 Dec; 13(6):451-8. PubMed ID: 14728801
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
20. The HNF1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation.
Sourdive DJ; Chouard T; Yaniv M
C R Acad Sci III; 1993; 316(4):385-94. PubMed ID: 8402264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
